The FDA has announced a public hearing and has requested comments on the subject of the use of opioid drugs in the treatment of chronic pain.
The public hearing will be held on February 7 and 8, 2013 from 9 a.m. to 4 p.m. in Bethesda, Maryland. There will be a live Web cast of the hearing. Information on how to view the live Web cast will be located at: http://www.fda.gov/Drugs/NewsEvents/ucm326450.htm .
In addition to the public hearing, the FDA is requesting electronic or written comments on the subject. Comments will be accepted until April 8, 2013.
This is our chance to have our voices heard by the people who are making the decisions!
Some of the issues they will be considering include:
Should opioids only be prescribed for “severe” pain?
Should there be a maximum daily dose allowed for opioids?
Should there be a limit on the number of days or months a patient can be prescribed a particular opioid?
Should opioid dosage vary depending ...
Metformin (generic) or Glucophage (brand) has become a very popular therapeutic agent in multiple medical conditions. According to David McCulloch (UpToDate 19.3- January, 2012) two classes of oral hypoglycemic medications directly improve insulin action: biguanides (metformin) and thiazolodinediones. Metformin is widely considered to be the first choice for oral therapy of type 2 diabetes based on the 2006 (and updated in 2009) consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Metformin is the only oral hypoglycemic medication that is generally approved for use in children with type 2 diabetes. It also is used as adjunctive medication in type 1 diabetes for other pathological states in pediatrics (to be described shortly).
How does Metformin work?
Metformin is only effective in the presence of insulin and its primary action is to decrease the amount of glucose produced by the liver. Metformin also increases insul...
Republished with approval from DiabetesMine.com .
Last summer I attended the American Association of Diabetes Educators ( AADE ) Annual Meeting in St. Louis, MO. I went there, as usual, to learn as much about the diabetes community and industry as I possibly can. I also went there armed with a writing assignment for Diabetes Health magazine. I thought I'd compose an article on "Educating the Educators," all about how CDEs get trained to help us. So I started interviewing everyone who had anything to do with diabetes education, from every angle -- from AADE presidents to CDE trainees to family physicians to the head of the certification board to (of course) affected patients. What I discovered was a field facing a crisis .
See the resulting exposé finally posted over at Diabetes Health magazine as of late last week.
It's no secret that the American healthcare system is a mess. It's actually been referred to as "a hairball" that may take a decade or two ...
You should knowAnswers to your question are meant to provide general health information but should not replace medical advice you receive from a doctor. No answers should be viewed as a diagnosis or recommended treatment for a condition. Content posted by community members does not necessarily reflect the views of Remedy Health Media, which also reserves the right to remove material deemed inappropriate.